Hypertension artérielle et démences

Ferri, 2005, Global prevalence of dementia: a Delphi consensus study, Lancet Neurol, 366, 2112, 10.1016/S0140-6736(05)67889-0 Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250 Launer, 2000, Mid-life blood pressure and dementia: the Honolulu-Asia aging study, Neurobiol Aging, 21, 49, 10.1016/S0197-4580(00)00096-8 Kivipelto, 2001, Mid-life vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 Yoshitake, 1995, Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study, Neurology, 45, 1161, 10.1212/WNL.45.6.1161 Qiu, 2003, Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study, Stroke, 34, 594, 10.1161/01.STR.0000060127.96986.F4 Wu, 2003, Relationship between blood pressure and Alzheimer's disease in Linxian County, China, Life Sci, 72, 1125, 10.1016/S0024-3205(02)02367-6 Yamada, 2003, Association between dementia and mid-life risk factors: the Radiation Effects Research Foundation Adult Health Study, J Am Geriatr Soc, 51, 410, 10.1046/j.1532-5415.2003.51117.x Luchsinger, 2005, Aggregation of vascular risk factors and risk of incident Alzheimer disease, Neurology, 65, 545, 10.1212/01.wnl.0000172914.08967.dc Freitag, 2006, Mid-life pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study, Stroke, 37, 33, 10.1161/01.STR.0000196941.58869.2d SHEP Cooperative Research Group, 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 Di Bari, 2001, Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial, Am J Epidemiol, 153, 72, 10.1093/aje/153.1.72 Forette, 1998, Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 2001, Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. PROGRESS Collaborative Group, Lancet, 358, 1033, 10.1016/S0140-6736(01)06178-5 Peters, 2008, HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo-controlled trial, Lancet Neurol, 7, 683, 10.1016/S1474-4422(08)70143-1 Blacher, 2013, The French Society of Hypertension. Management of hypertension in adults: the 2013 French Society of Hypertension guidelines, Fundam Clin Pharmacol Pasquier, 1997, Why are stroke patients prone to develop dementia?, J Neurol, 244, 135, 10.1007/s004150050064 Desmond, 2000, Frequency and clinical determinants of dementia after ischemic stroke, Neurology, 54, 1124, 10.1212/WNL.54.5.1124 Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer disease. The Nun Study, JAMA, 277, 813, 10.1001/jama.1997.03540340047031 Debette, 2010, The clinical importance of white matter hyperintensities, BMJ, 341, c3666, 10.1136/bmj.c3666 Prins, 2004, Cerebral white matter lesions and the risk of dementia, Arch Neurol, 61, 1531, 10.1001/archneur.61.10.1531 Longstreth, 1996, Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study, Stroke, 27, 1274, 10.1161/01.STR.27.8.1274